ReviewJournal of pain research2025
Core Outcome Sets for Pain Disorders: A Systematic Review of Research and Reporting Quality.
Review in Journal of pain research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To systematically review the current research status of Core Outcome Sets (COS) for pain-related diseases and to evaluate the methodological quality of existing COS. Methods: Two researchers independently conducted a comprehensive search of both English and Chinese databases. Studies were screened and data were extracted based on predefined inclusion criteria. The methodological quality of the identified COS was assessed using the Core Outcome Set-STAndards for Development (COS-STAD), which includes 11 criteria covering the scope, stakeholder involvement, and the consensus process. Results: 24 COS were included in the final analysis out of 2150 records initially identified. These COS were primarily developed by organizations or research teams in Europe, Asia, and North America. The included COS covered 22 pain-related disorders, most of which (8 [33%]) were classified as symptoms, signs, or clinical findings according to the ICD-11 classification. One or more of the eight recognized methodologies were used in developing each COS. The most common combination included systematic reviews, Delphi surveys, qualitative interviews, and consensus meetings (6 [25%]). Among key stakeholder groups, clinical experts were most frequently involved (22 [92%]), whereas industry representatives were less engaged (5 [21%]). Only 5 COS (20%) fully met the 11 COS-STAD criteria, indicating room for methodological improvement. The highest scores were for health issue coverage (24/24 points), followed by the involvement of healthcare professionals in reflecting disease experiences (23/24 points). In contrast, the average score for intervention coverage was lowest (15/24), followed by constructing the initial outcome list (18/24). These findings suggest that greater emphasis should be placed on incorporating the perspectives of both professionals and patients during the initial outcome selection process. Conclusion: The development of Core Outcome Sets should adhere closely to guidelines established by the Core Outcome Measures in Effectiveness Trials (COMET) Initiative. Greater emphasis should be placed on the inclusion and evaluation of interventions. In addition, the perspectives of healthcare professionals and patients should be more thoroughly integrated during the design of the initial outcome list to enhance the relevance and applicability of COS in clinical practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.